NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.
Odqvist L, Sánchez-Beato M, Montes-Moreno S, Martín-Sánchez E, Pajares R, Sánchez-Verde L, Ortiz-Romero PL, Rodriguez J, Rodríguez-Pinilla SM, Iniesta-Martínez F, Solera-Arroyo JC, Ramos-Asensio R, Flores T, Palanca JM, Bragado FG, Franjo PD, Piris MA.
Odqvist L, et al. Among authors: sanchez verde l.
Clin Cancer Res. 2013 May 1;19(9):2319-30. doi: 10.1158/1078-0432.CCR-12-3151. Epub 2013 Mar 27.
Clin Cancer Res. 2013.
PMID: 23536439